Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Marielle Scherrer-Crosbie"'
Autor:
Julia Matzenbacher dos Santos, Aby Joiakim, David A. Putt, Marielle Scherrer-Crosbie, Hyesook Kim
Publikováno v:
Cardio-Oncology, Vol 9, Iss 1, Pp 1-12 (2023)
Abstract Background Early identification of patients susceptible to chemotherapy-induced cardiotoxicity could lead to targeted treatment to reduce cardiac dysfunction. Rats treated with doxorubicin (DOX), a chemotherapeutic agent, have increased card
Externí odkaz:
https://doaj.org/article/0bacaf7405514e8ba86dc388cbe1dd2f
Autor:
Gillian Murtagh, James L. Januzzi, Marielle Scherrer‐Crosbie, Tomas G. Neilan, Susan Dent, Jennifer E. Ho, Vinesh Appadurai, Ray McDermott, Nausheen Akhter
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 21 (2023)
ABSTRACT Cardiotoxicity is a growing concern in the oncology population. Transthoracic echocardiography and multigated acquisition scans have been used for surveillance but are relatively insensitive and resource intensive. Innovative imaging techniq
Externí odkaz:
https://doaj.org/article/fff5d80966a54a05b23e19381cc66a9c
Autor:
Abdulaziz Hamid, James MacLeod, Samuel Erb, Generika Berman, Hugo R. Martinez, Marielle Scherrer-Crosbie, Richard K. Cheng, Sherry-Ann Brown
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/0b9c69b6d8624b5ba6a6f1da3af7a2c1
Autor:
Ruth Tamrat, Yu Kang, Marielle Scherrer‐Crosbie, Lisa D. Levine, Zoltan Arany, Jennifer Lewey
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 3382-3386 (2021)
Abstract We report a case series of six women with peripartum cardiomyopathy (PPCM) who incidentally underwent echocardiography prior to the clinical presentation of PPCM. For comparison, we identified controls, matched 2:1 on age, race, body mass in
Externí odkaz:
https://doaj.org/article/a4bef099e149456693a9b51adec12581
Autor:
Sherry-Ann Brown, Generika Berman, Jim Logan, Diego Sadler, Rohit Moudgil, Brijesh Patel, Marielle Scherrer-Crosbie, Daniel Addison, Richard K. Cheng, Arco J. Teske
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/2e81b1e70f7a434b927f1835df3cb992
Autor:
Ling Yu, Read Allen, Lin Jia, Ting Sun, Steven J. Isakoff, Marielle Scherrer-Crosbie, Allison M. Kehlmann, Hui Zheng, Amy Ly, Charlotte S. Walmsley, Katherine Hesler, Ava N. Varasteh, Christopher J. Pinto, Daniel E. McLoughlin, Wenjin Wu, Xinhui Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundTrastuzumab is a targeted therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, trastuzumab-induced cardiotoxicity (TIC) has been reported when trastuzumab is administered to patients as a single agent
Externí odkaz:
https://doaj.org/article/3d195d2bb1e644cabb2a0e090b1d001e
Autor:
Nidhi Madan, Julliette Lucas, Nausheen Akhter, Patrick Collier, Feixiong Cheng, Avirup Guha, Lili Zhang, Abhinav Sharma, Abdulaziz Hamid, Imeh Ndiokho, Ethan Wen, Noelle C. Garster, Marielle Scherrer-Crosbie, Sherry-Ann Brown
Publikováno v:
American Heart Journal Plus, Vol 15, Iss , Pp 100126- (2022)
Cardiovascular disease is a leading cause of death in cancer survivors. It is critical to apply new predictive and early diagnostic methods in this population, as this can potentially inform cardiovascular treatment and surveillance decision-making.
Externí odkaz:
https://doaj.org/article/b6e59096997a42f1a753a9473446bdfe
Autor:
Bénédicte Lefebvre, MD, Yu Kang, MD, PhD, Amanda M. Smith, MA, Noelle V. Frey, MD, Joseph R. Carver, MD, Marielle Scherrer-Crosbie, MD, PhD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 2, Pp 193-203 (2020)
Background: Anti-CD19 chimeric antigen receptor (CAR) T cell therapy holds great promise in the treatment of patients with hematologic malignancies. A high occurrence of cardiac dysfunction has been noted in children treated with CAR T cell therapy.
Externí odkaz:
https://doaj.org/article/6c7e1e696d0e4efe891b54b0999308a2
Autor:
Yu Kang, MD, PhD, Bruna Leal Assuncao, MD, Srinivas Denduluri, PhD, Shannon McCurdy, MD, Selina Luger, MD, Bénédicte Lefebvre, MD, Joseph Carver, MD, Marielle Scherrer-Crosbie, MD, PhD
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 2, Pp 208-217 (2019)
Objectives: The purpose of this study was to investigate the occurrence and develop a risk score for heart failure (HF) in acute leukemia. Background: Knowledge is scarce regarding the incidence and risk factors of symptomatic HF in patients with acu
Externí odkaz:
https://doaj.org/article/6fb23c2dc2eb4d6ebe398edf22108e5a
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85946 (2014)
Myocardial infarction resulting from ischemia-reperfusion injury can be reduced by cardiac postconditioning, in which blood flow is restored intermittently prior to full reperfusion. Although key molecular mechanisms and prosurvival pathways involved
Externí odkaz:
https://doaj.org/article/2394c4cd90cb467c80b2d6240d1abcdc